Global Oncology Blood Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 195653
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Oncology Blood Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oncology Blood Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Oncology Blood Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Oncology Blood Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Blood Protein Testing

Tumor Marker Testing

Others

Market segment by Application, can be divided into

Hospitals

Clinics

Ambulatory Surgical Centers

Market segment by players, this report covers

Guardant Health

Trovagene

Genomic Health

Roche

Bio-Techne

Pathway Genomics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Oncology Blood Testing

1.2 Classification of Oncology Blood Testing by Type

1.2.1 Overview: Global Oncology Blood Testing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Oncology Blood Testing Revenue Market Share by Type in 2020

1.2.3 Blood Protein Testing

1.2.4 Tumor Marker Testing

1.2.5 Others

1.3 Global Oncology Blood Testing Market by Application

1.3.1 Overview: Global Oncology Blood Testing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Oncology Blood Testing Market Size & Forecast

1.5 Global Oncology Blood Testing Market Size and Forecast by Region

1.5.1 Global Oncology Blood Testing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Oncology Blood Testing Market Size by Region, (2016-2021)

1.5.3 North America Oncology Blood Testing Market Size and Prospect (2016-2026)

1.5.4 Europe Oncology Blood Testing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Oncology Blood Testing Market Size and Prospect (2016-2026)

1.5.6 South America Oncology Blood Testing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Oncology Blood Testing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oncology Blood Testing Market Drivers

1.6.2 Oncology Blood Testing Market Restraints

1.6.3 Oncology Blood Testing Trends Analysis

2 Company Profiles

2.1 Guardant Health

2.1.1 Guardant Health Details

2.1.2 Guardant Health Major Business

2.1.3 Guardant Health Oncology Blood Testing Product and Solutions

2.1.4 Guardant Health Oncology Blood Testing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Guardant Health Recent Developments and Future Plans

2.2 Trovagene

2.2.1 Trovagene Details

2.2.2 Trovagene Major Business

2.2.3 Trovagene Oncology Blood Testing Product and Solutions

2.2.4 Trovagene Oncology Blood Testing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Trovagene Recent Developments and Future Plans

2.3 Genomic Health

2.3.1 Genomic Health Details

2.3.2 Genomic Health Major Business

2.3.3 Genomic Health Oncology Blood Testing Product and Solutions

2.3.4 Genomic Health Oncology Blood Testing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Genomic Health Recent Developments and Future Plans

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche Oncology Blood Testing Product and Solutions

2.4.4 Roche Oncology Blood Testing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Roche Recent Developments and Future Plans

2.5 Bio-Techne

2.5.1 Bio-Techne Details

2.5.2 Bio-Techne Major Business

2.5.3 Bio-Techne Oncology Blood Testing Product and Solutions

2.5.4 Bio-Techne Oncology Blood Testing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Bio-Techne Recent Developments and Future Plans

2.6 Pathway Genomics

2.6.1 Pathway Genomics Details

2.6.2 Pathway Genomics Major Business

2.6.3 Pathway Genomics Oncology Blood Testing Product and Solutions

2.6.4 Pathway Genomics Oncology Blood Testing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Pathway Genomics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Oncology Blood Testing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Oncology Blood Testing Players Market Share

3.2.2 Top 10 Oncology Blood Testing Players Market Share

3.2.3 Market Competition Trend

3.3 Oncology Blood Testing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Oncology Blood Testing Revenue and Market Share by Type (2016-2021)

4.2 Global Oncology Blood Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Oncology Blood Testing Revenue Market Share by Application (2016-2021)

5.2 Oncology Blood Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Oncology Blood Testing Revenue by Type (2016-2026)

6.2 North America Oncology Blood Testing Revenue by Application (2016-2026)

6.3 North America Oncology Blood Testing Market Size by Country

6.3.1 North America Oncology Blood Testing Revenue by Country (2016-2026)

6.3.2 United States Oncology Blood Testing Market Size and Forecast (2016-2026)

6.3.3 Canada Oncology Blood Testing Market Size and Forecast (2016-2026)

6.3.4 Mexico Oncology Blood Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Oncology Blood Testing Revenue by Type (2016-2026)

7.2 Europe Oncology Blood Testing Revenue by Application (2016-2026)

7.3 Europe Oncology Blood Testing Market Size by Country

7.3.1 Europe Oncology Blood Testing Revenue by Country (2016-2026)

7.3.2 Germany Oncology Blood Testing Market Size and Forecast (2016-2026)

7.3.3 France Oncology Blood Testing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Oncology Blood Testing Market Size and Forecast (2016-2026)

7.3.5 Russia Oncology Blood Testing Market Size and Forecast (2016-2026)

7.3.6 Italy Oncology Blood Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oncology Blood Testing Revenue by Type (2016-2026)

8.2 Asia-Pacific Oncology Blood Testing Revenue by Application (2016-2026)

8.3 Asia-Pacific Oncology Blood Testing Market Size by Region

8.3.1 Asia-Pacific Oncology Blood Testing Revenue by Region (2016-2026)

8.3.2 China Oncology Blood Testing Market Size and Forecast (2016-2026)

8.3.3 Japan Oncology Blood Testing Market Size and Forecast (2016-2026)

8.3.4 South Korea Oncology Blood Testing Market Size and Forecast (2016-2026)

8.3.5 India Oncology Blood Testing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Oncology Blood Testing Market Size and Forecast (2016-2026)

8.3.7 Australia Oncology Blood Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Oncology Blood Testing Revenue by Type (2016-2026)

9.2 South America Oncology Blood Testing Revenue by Application (2016-2026)

9.3 South America Oncology Blood Testing Market Size by Country

9.3.1 South America Oncology Blood Testing Revenue by Country (2016-2026)

9.3.2 Brazil Oncology Blood Testing Market Size and Forecast (2016-2026)

9.3.3 Argentina Oncology Blood Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oncology Blood Testing Revenue by Type (2016-2026)

10.2 Middle East & Africa Oncology Blood Testing Revenue by Application (2016-2026)

10.3 Middle East & Africa Oncology Blood Testing Market Size by Country

10.3.1 Middle East & Africa Oncology Blood Testing Revenue by Country (2016-2026)

10.3.2 Turkey Oncology Blood Testing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Oncology Blood Testing Market Size and Forecast (2016-2026)

10.3.4 UAE Oncology Blood Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Oncology Blood Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Oncology Blood Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Oncology Blood Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Oncology Blood Testing Revenue (USD Million) by Region (2016-2021)

Table 5. Global Oncology Blood Testing Revenue Market Share by Region (2021-2026)

Table 6. Guardant Health Corporate Information, Head Office, and Major Competitors

Table 7. Guardant Health Major Business

Table 8. Guardant Health Oncology Blood Testing Product and Solutions

Table 9. Guardant Health Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Trovagene Corporate Information, Head Office, and Major Competitors

Table 11. Trovagene Major Business

Table 12. Trovagene Oncology Blood Testing Product and Solutions

Table 13. Trovagene Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Genomic Health Corporate Information, Head Office, and Major Competitors

Table 15. Genomic Health Major Business

Table 16. Genomic Health Oncology Blood Testing Product and Solutions

Table 17. Genomic Health Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Roche Corporate Information, Head Office, and Major Competitors

Table 19. Roche Major Business

Table 20. Roche Oncology Blood Testing Product and Solutions

Table 21. Roche Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Bio-Techne Corporate Information, Head Office, and Major Competitors

Table 23. Bio-Techne Major Business

Table 24. Bio-Techne Oncology Blood Testing Product and Solutions

Table 25. Bio-Techne Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Pathway Genomics Corporate Information, Head Office, and Major Competitors

Table 27. Pathway Genomics Major Business

Table 28. Pathway Genomics Oncology Blood Testing Product and Solutions

Table 29. Pathway Genomics Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Global Oncology Blood Testing Revenue (USD Million) by Players (2019-2021)

Table 31. Global Oncology Blood Testing Revenue Share by Players (2019-2021)

Table 32. Breakdown of Oncology Blood Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. Oncology Blood Testing Players Head Office, Products and Services Provided

Table 34. Oncology Blood Testing Mergers & Acquisitions in the Past Five Years

Table 35. Oncology Blood Testing New Entrants and Expansion Plans

Table 36. Global Oncology Blood Testing Revenue (USD Million) by Type (2016-2021)

Table 37. Global Oncology Blood Testing Revenue Share by Type (2016-2021)

Table 38. Global Oncology Blood Testing Revenue Forecast by Type (2021-2026)

Table 39. Global Oncology Blood Testing Revenue by Application (2016-2021)

Table 40. Global Oncology Blood Testing Revenue Forecast by Application (2021-2026)

Table 41. North America Oncology Blood Testing Revenue by Type (2016-2021) & (USD Million)

Table 42. North America Oncology Blood Testing Revenue by Type (2021-2026) & (USD Million)

Table 43. North America Oncology Blood Testing Revenue by Application (2016-2021) & (USD Million)

Table 44. North America Oncology Blood Testing Revenue by Application (2021-2026) & (USD Million)

Table 45. North America Oncology Blood Testing Revenue by Country (2016-2021) & (USD Million)

Table 46. North America Oncology Blood Testing Revenue by Country (2021-2026) & (USD Million)

Table 47. Europe Oncology Blood Testing Revenue by Type (2016-2021) & (USD Million)

Table 48. Europe Oncology Blood Testing Revenue by Type (2021-2026) & (USD Million)

Table 49. Europe Oncology Blood Testing Revenue by Application (2016-2021) & (USD Million)

Table 50. Europe Oncology Blood Testing Revenue by Application (2021-2026) & (USD Million)

Table 51. Europe Oncology Blood Testing Revenue by Country (2016-2021) & (USD Million)

Table 52. Europe Oncology Blood Testing Revenue by Country (2021-2026) & (USD Million)

Table 53. Asia-Pacific Oncology Blood Testing Revenue by Type (2016-2021) & (USD Million)

Table 54. Asia-Pacific Oncology Blood Testing Revenue by Type (2021-2026) & (USD Million)

Table 55. Asia-Pacific Oncology Blood Testing Revenue by Application (2016-2021) & (USD Million)

Table 56. Asia-Pacific Oncology Blood Testing Revenue by Application (2021-2026) & (USD Million)

Table 57. Asia-Pacific Oncology Blood Testing Revenue by Region (2016-2021) & (USD Million)

Table 58. Asia-Pacific Oncology Blood Testing Revenue by Region (2021-2026) & (USD Million)

Table 59. South America Oncology Blood Testing Revenue by Type (2016-2021) & (USD Million)

Table 60. South America Oncology Blood Testing Revenue by Type (2021-2026) & (USD Million)

Table 61. South America Oncology Blood Testing Revenue by Application (2016-2021) & (USD Million)

Table 62. South America Oncology Blood Testing Revenue by Application (2021-2026) & (USD Million)

Table 63. South America Oncology Blood Testing Revenue by Country (2016-2021) & (USD Million)

Table 64. South America Oncology Blood Testing Revenue by Country (2021-2026) & (USD Million)

Table 65. Middle East & Africa Oncology Blood Testing Revenue by Type (2016-2021) & (USD Million)

Table 66. Middle East & Africa Oncology Blood Testing Revenue by Type (2021-2026) & (USD Million)

Table 67. Middle East & Africa Oncology Blood Testing Revenue by Application (2016-2021) & (USD Million)

Table 68. Middle East & Africa Oncology Blood Testing Revenue by Application (2021-2026) & (USD Million)

Table 69. Middle East & Africa Oncology Blood Testing Revenue by Country (2016-2021) & (USD Million)

Table 70. Middle East & Africa Oncology Blood Testing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Oncology Blood Testing Picture

Figure 2. Global Oncology Blood Testing Revenue Market Share by Type in 2020

Figure 3. Blood Protein Testing

Figure 4. Tumor Marker Testing

Figure 5. Others

Figure 6. Oncology Blood Testing Revenue Market Share by Application in 2020

Figure 7. Hospitals Picture

Figure 8. Clinics Picture

Figure 9. Ambulatory Surgical Centers Picture

Figure 10. Global Oncology Blood Testing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Oncology Blood Testing Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Oncology Blood Testing Revenue Market Share by Region (2016-2026)

Figure 13. Global Oncology Blood Testing Revenue Market Share by Region in 2020

Figure 14. North America Oncology Blood Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Oncology Blood Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Oncology Blood Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Oncology Blood Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Oncology Blood Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Oncology Blood Testing Market Drivers

Figure 20. Oncology Blood Testing Market Restraints

Figure 21. Oncology Blood Testing Market Trends

Figure 22. Guardant Health Recent Developments and Future Plans

Figure 23. Trovagene Recent Developments and Future Plans

Figure 24. Genomic Health Recent Developments and Future Plans

Figure 25. Roche Recent Developments and Future Plans

Figure 26. Bio-Techne Recent Developments and Future Plans

Figure 27. Pathway Genomics Recent Developments and Future Plans

Figure 28. Global Oncology Blood Testing Revenue Share by Players in 2020

Figure 29. Oncology Blood Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 30. Global Top 3 Players Oncology Blood Testing Revenue Market Share in 2020

Figure 31. Global Top 10 Players Oncology Blood Testing Revenue Market Share in 2020

Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 33. Global Oncology Blood Testing Revenue Share by Type in 2020

Figure 34. Global Oncology Blood Testing Market Share Forecast by Type (2021-2026)

Figure 35. Global Oncology Blood Testing Revenue Share by Application in 2020

Figure 36. Global Oncology Blood Testing Market Share Forecast by Application (2021-2026)

Figure 37. North America Oncology Blood Testing Sales Market Share by Type (2016-2026)

Figure 38. North America Oncology Blood Testing Sales Market Share by Application (2016-2026)

Figure 39. North America Oncology Blood Testing Revenue Market Share by Country (2016-2026)

Figure 40. United States Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Oncology Blood Testing Sales Market Share by Type (2016-2026)

Figure 44. Europe Oncology Blood Testing Sales Market Share by Application (2016-2026)

Figure 45. Europe Oncology Blood Testing Revenue Market Share by Country (2016-2026)

Figure 46. Germany Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. France Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. United Kingdom Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Russia Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Italy Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Asia-Pacific Oncology Blood Testing Sales Market Share by Type (2016-2026)

Figure 52. Asia-Pacific Oncology Blood Testing Sales Market Share by Application (2016-2026)

Figure 53. Asia-Pacific Oncology Blood Testing Revenue Market Share by Region (2016-2026)

Figure 54. China Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Japan Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. South Korea Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. India Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Southeast Asia Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Australia Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. South America Oncology Blood Testing Sales Market Share by Type (2016-2026)

Figure 61. South America Oncology Blood Testing Sales Market Share by Application (2016-2026)

Figure 62. South America Oncology Blood Testing Revenue Market Share by Country (2016-2026)

Figure 63. Brazil Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Argentina Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Middle East and Africa Oncology Blood Testing Sales Market Share by Type (2016-2026)

Figure 66. Middle East and Africa Oncology Blood Testing Sales Market Share by Application (2016-2026)

Figure 67. Middle East and Africa Oncology Blood Testing Revenue Market Share by Country (2016-2026)

Figure 68. Turkey Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Saudi Arabia Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. UAE Oncology Blood Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Methodology

Figure 72. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz